Jump to content

Where to next for Walgreens shares as owner abandons sale of Boots chain?


Recommended Posts

Is the Walgreens share price likely to continue its slide as it halts the sale of Boots?

bg_stock_market_performance_365376363.jpSource: Bloomberg
 Axel Rudolph | Market Analyst, London | Publication date: Wednesday 29 June 2022 

Detrimental financial conditions made Walgreens pull the plug on its Boots sale

Citing tougher financial conditions following the upheaval in credit markets, Walgreens Boots Alliance, the owner of the UK pharmacy and beauty group Boots, announced on Tuesday that it has abandoned its sale of Britain’s biggest chemist as recent bids didn’t meet its expectations.

The US pharmacy company said on Tuesday that while there had been “significant interest” in the near 175-year-old business, it “has decided that it is in the best interests of shareholders to keep focusing on the further growth and profitability of the two businesses” and that an “unexpected and dramatic change” in the financial markets meant no offers had been received that reflected the potential value of Boots.

Boots and its related No.7 beauty brand account for around five per cent of its parent’s $132 billion in annual sales. American pharmaceutical company, Walgreens has been looking to sell its UK Boots and No.7 beauty brand since the end of 2021, with a formal review of its options beginning in January of this year.

However, Russia’s invasion of Ukraine, followed by rapidly rising interest rates in both the US and the UK, have made it very difficult for new issuers to operate within Europe’s high-yield credit market since financing any highly leveraged bids has become very costly.

Walgreens had apparently been looking for as much as £10bn when it initially put Boots up for sale, as it sought to focus on its US businesses but after several failed bids, some apparently coming close to their valuation earlier this year, it finally pulled the plug on the Boots sale as the financial environment for bids worsened. “As a result of market instability severely impacting financing availability, no third party has been able to make an offer that adequately reflects the high potential value of Boots and No.7 Beauty Company”, the company stated.

Walgreens insisted, however, that the abandoned sale of Boots should not reflect badly on the performance of the main UK chemist or the No.7 brand, saying they were continuing to grow and perform strongly.

The US Boots owner also assured investors that it would continue to invest in the company, which has “exceeded expectations despite challenging conditions”.

Despite halting the Boots sale at present, Walgreens’ chief executive, Rosalind Brewer, signalled that the company will “stay open to all opportunities to maximise shareholder value.”

Walgreens weekly chartSource: ProRealTime

Where to next for the Walgreens Boots Alliance share price?

With the Walgreens share price down around 20% year-to-date and evolving in a clearly defined downtrend channel since the beginning of the year, and having this week topped out near its November 2021 low at $42.68 on the news that Boots is no longer up for sale, further downside looks to be in store.

While the 55-day simple moving average (SMA) continues to cap the share price on a daily chart closing basis, as it has been doing since mid-February, the current June low at $39.15 remains in focus.

If slid through, the late December 2020 low at $36.79 will be next in line, followed by the 78.6% Fibonacci retracement of the 2020-to-2021 advance at $36.15.

Walgreens daily chartSource: ProRealTime

 

Since one can clearly make out a series of lower highs and lower lows – the definition of a downtrend – the technical picture for Walgreens remains negative for now.

For the downtrend to be broken and reversed at least two daily chart higher highs and higher lows would need to be seen and take the Walgreens share price to above not only this week’s high but also above the May and current June highs at $43.95 to $44.75. Only then could one envisage the 200-day SMA at $46.22 being back in sight.

Below it the Walgreens stock is considered to be in bear market territory. Unless such a bullish reversal is seen in the days and weeks to come, further slides in the Walgreens share price are likely to ensue.

Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • image.png

  • Posts

    • Ondo finance is a project that is aimed to democratise access to institutional grade financial products and services using blockchain technology.  The project’s team seeks to leverage on the blockchain technology, to improve both the financial infrastructure and accessibility of financial products. The team cuts across former members of reputable firms like Goldman Sachs and partnerships with VCs like; Blackrock and Morgan Stanley. Practically, it seeks to integrate the real world assets with blockchain technology. The native token $ONDO has performed exceedingly well since its launch in January18th, 2024. The tokenized products offered by the project have a bearing to US treasuries and the US money market funds. After keenly reading about this project it is quite clear that it is a fine blend of tradfi and defi product services. With this immense usecase, $ONDO will do very well. Looking at these, T1 platforms like Bitget have listed it and the price action is quite fair thus.        
    • You all will agree with me that many of us tends to focus on big names like BTC, ETH, SOL, and XRP. I've followed this trend too. But lately, I've realized there's a whole world of opportunities beyond these mainstream coins. Taking a closer look at the market: BTC and ETH haven't doubled since the start of 2024. Meanwhile, some lesser-known crypto projects have shot up by 400% and more. I am not talking about memecoins  Just today while reading an article about ONDO and ZEEBU published by Bitget, I was amazed to see the incredible growth these two tokens have undergone in the past few months. While ONDO deals with tokenized real-world assets, ZEEBU is a loyalty token for smoother global transactions, rewarding users along the way. Both have seen incredible growth recently. Sure, holding BTC has its perks, but tokens like ONDO and ZEEBU are gaining traction fast. They've already hit billion-dollar market caps from humble beginnings. It seems like these underdog projects might be the ones to watch during this bullish phase. But the challenge remains: how do we identify gems in this evolving landscape?
    • Dopamine emerges as a beacon of innovation in the world of cryptocurrency management, offering a non-custodial, secure, and anonymous mobile app wallet. With over two million downloads and a robust user base, Dopamine is reshaping the landscape of decentralized finance (DeFi) on both Android and iOS platforms. Let's delve into the features and functionalities that make Dopamine a must-have tool for navigating the cryptocurrency market. Key Features: 1. Comprehensive Portfolio Tracking: Dopamine's native token, $DOPE, empowers users to monitor their favorite projects from a vast collection of over 10,000 coins, ensuring informed decision-making in the dynamic crypto market. 2. Enhanced Security Measures: With built-in Anti-Money Laundering services, Dopamine enables users to safeguard their assets by identifying potential fraud and assessing risk scores associated with their wallets. 3. Real-Time Market Insights: Stay ahead of the curve with Dopamine's ability to track market trends and identify coins making significant moves, ensuring users remain informed and proactive in their investment strategies. 4. Cross-Chain NFT Transactions: Seamlessly send and receive NFTs across various blockchains, including Ethereum, BSC, Fusion, and more, providing users with unparalleled flexibility and interoperability. 5. Efficient Information Management: Dopamine simplifies data management by allowing users to save essential information and access it instantly, streamlining their crypto journey with convenience and ease. 6. Convenient Fiat On-Ramp: Facilitating seamless transactions, Dopamine enables users to buy crypto directly from their credit or debit card within the app, eliminating the need for multiple platforms and intermediaries. 7. DeFi Gaming Integration: Dive into the exciting world of decentralized finance gaming with Dopamine, offering users access to a diverse range of DeFi games directly from the app, adding a touch of entertainment to their crypto experience. With its innovative features, commitment to user empowerment and upcoming listing on Bitget exchange, Dopamine stands as a revolutionary platform that caters to the diverse needs of cryptocurrency enthusiasts. As the cryptocurrency market continues to evolve, It remains at the forefront, providing users with a secure, versatile, and intuitive solution for managing their digital assets and exploring new horizons in decentralized finance.
×
×
  • Create New...
us